A detailed history of Ruggaard & Associates LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Ruggaard & Associates LLC holds 3,124 shares of ABT stock, worth $327,301. This represents 0.17% of its overall portfolio holdings.

Number of Shares
3,124
Previous 3,135 0.35%
Holding current value
$327,301
Previous $345 Million 2.92%
% of portfolio
0.17%
Previous 0.18%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$109.52 - $120.96 $1,204 - $1,330
-11 Reduced 0.35%
3,124 $355 Million
Q4 2023

Feb 15, 2024

BUY
$90.19 - $110.4 $28,049 - $34,334
311 Added 11.01%
3,135 $345 Million
Q3 2023

Nov 09, 2023

BUY
$95.53 - $114.62 $2,770 - $3,323
29 Added 1.04%
2,824 $274 Million
Q2 2023

Aug 10, 2023

BUY
$100.78 - $112.29 $4,031 - $4,491
40 Added 1.45%
2,795 $305 Million
Q1 2023

May 15, 2023

BUY
$96.86 - $114.01 $266,849 - $314,097
2,755 New
2,755 $279 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $183B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Ruggaard & Associates LLC Portfolio

Follow Ruggaard & Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ruggaard & Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ruggaard & Associates LLC with notifications on news.